Altered dynamics of a lipid raft associated protein in a kidney model of Fabry disease

被引:20
作者
Labilloy, Anatalia [1 ,2 ,3 ]
Youker, Robert T. [1 ]
Bruns, Jennifer R. [1 ]
Kukic, Ira [4 ]
Kiselyov, Kirill [4 ]
Halfter, Willi [5 ]
Finegold, David [2 ]
Hadad do Monte, Semiramis Jamil [6 ]
Weisz, Ora A. [1 ]
机构
[1] Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA
[3] CNPq, Ciencia Sem Fronteiras, Brasilia, DF, Brazil
[4] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA
[5] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA
[6] Univ Fed Piaui, Immunogenet & Mol Biol Lab, BR-64049550 Teresina, PI, Brazil
基金
美国国家卫生研究院;
关键词
Fabry disease; Lipid rafts; GPI-anchored proteins; Number and brightness analysis; Kidney; Polarized sorting; GPI-ANCHORED PROTEINS; ENZYME-REPLACEMENT THERAPY; AGALSIDASE BETA TREATMENT; APICAL MEMBRANE; ALPHA-GALACTOSIDASE; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; RENAL PATHOLOGY; DOWN-REGULATION; LIVING CELLS;
D O I
10.1016/j.ymgme.2013.10.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Accumulation of globotriaosylceramide (Gb3) and other neutral glycosphingolipids with galactosyl residues is the hallmark of Fabry disease, a lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A (alpha-gal A). These lipids are incorporated into the plasma membrane and intracellular membranes, with a preference for lipid rafts. Disruption of raft mediated cell processes is implicated in the pathogenesis of several human diseases, but little is known about the effects of the accumulation of glycosphingolipids on raft dynamics in the context of Fabry disease. Using siRNA technology, we have generated a polarized renal epithelial cell model of Fabry disease in Madin-Darby canine kidney cells. These cells present increased levels of Gb3 and enlarged lysosomes, and progressively accumulate zebra bodies. The polarized delivery of both raft-associated and raft-independent proteins was unaffected by alpha-gal A knockdown, suggesting that accumulation of Gb3 does not disrupt biosynthetic trafficking pathways. To assess the effect of alpha-gal A silencing on lipid raft dynamics, we employed number and brightness (N&B) analysis to measure the oligomeric status and mobility of the model glycosylphosphatidylinositol (GPI)-anchored protein GFP-GPI. We observed a significant increase in the oligomeric size of antibody-induced clusters of GFP-GPI at the plasma membrane of alpha-gal A silenced cells compared with control cells. Our results suggest that the interaction of GFP-GPI with lipid rafts may be altered in the presence of accumulated Gb3. The implications of our results with respect to the pathogenesis of Fabry disease are discussed. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:184 / 192
页数:9
相关论文
共 74 条
[61]  
Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/NCHEMBIO.1028, 10.1038/nchembio.1028]
[62]   Downregulation of α-galactosidase A upregulates CD77: functional impact for Fabry nephropathy [J].
Thomaidis, Thomas ;
Relle, Manfred ;
Golbas, Mitra ;
Brochhausen, Christoph ;
Galle, Peter R. ;
Beck, Michael ;
Schwarting, Andreas .
KIDNEY INTERNATIONAL, 2009, 75 (04) :399-407
[63]   Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease [J].
Tondel, Camilla ;
Bostad, Leif ;
Larsen, Kristin Kampevold ;
Hirth, Asle ;
Vikse, Bjorn Egil ;
Houge, Gunnar ;
Svarstad, Einar .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (01) :137-148
[64]   Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice [J].
Vruchte, Danielle Te ;
Jeans, Aruna ;
Platt, Frances M. ;
Sillence, Daniel John .
JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (03) :261-270
[65]   Lipid raft regulates the initial spreading of melanoma A375 cells by modulating β1 integrin clustering [J].
Wang, Ruifei ;
Bi, Jiajia ;
Ampah, Khamal Kwesi ;
Zhang, Chunmei ;
Li, Ziyi ;
Jiao, Yang ;
Wang, Xiaoru ;
Ba, Xueqing ;
Zeng, Xianlu .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (08) :1679-1689
[66]   Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation [J].
Warnock, David G. ;
Ortiz, Alberto ;
Mauer, Michael ;
Linthorst, Gabor E. ;
Oliveira, Joao P. ;
Serra, Andreas L. ;
Marodi, Laszlo ;
Mignani, Renzo ;
Vujkovac, Bojan ;
Beitner-Johnson, Dana ;
Lemay, Roberta ;
Cole, J. Alexander ;
Svarstad, Einar ;
Waldek, Stephen ;
Germain, Dominique P. ;
Wanner, Christoph .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (03) :1042-1049
[67]   Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry [J].
Watt, Torquil ;
Burlina, Alessandro P. ;
Cazzorla, Chiara ;
Schoenfeld, Dorothee ;
Banikazemi, Maryam ;
Hopkin, Robert J. ;
Martins, Ana Maria ;
Sims, Katherine ;
Beitner-Johnson, Dana ;
O'Brien, Fanny ;
Feldt-Rasmussen, Ulla .
GENETICS IN MEDICINE, 2010, 12 (11) :703-712
[68]   Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications [J].
Weidemann, F. ;
Niemann, M. ;
Stoerk, S. ;
Breunig, F. ;
Beer, M. ;
Sommer, C. ;
Herrmann, S. ;
Ertl, G. ;
Wanner, C. .
JOURNAL OF INTERNAL MEDICINE, 2013, 274 (04) :331-341
[69]   Apical trafficking in epithelial cells: signals, clusters and motors [J].
Weisz, Ora A. ;
Rodriguez-Boulan, Enrique .
JOURNAL OF CELL SCIENCE, 2009, 122 (23) :4253-4266
[70]   Persistence of Psychosine in Brain Lipid Rafts Is a Limiting Factor in the Therapeutic Recovery of a Mouse Model for Krabbe Disease [J].
White, A. B. ;
Galbiati, F. ;
Givogri, M. I. ;
Rosas, A. Lopez ;
Qiu, X. ;
van Breemen, R. ;
Bongarzonel, E. R. .
JOURNAL OF NEUROSCIENCE RESEARCH, 2011, 89 (03) :352-364